Covifor

With the state running out of Covishield vaccines today and a Covaxin stock of just 112821 doses, Punjab Chief Minister Captain Amarinder Singh has reiterated the demand for supply of more vaccines by the Centre to vaccinate the entire…

The Centre on Tuesday granted approval to the Moderna Covid-19 vaccine to enter the Indian market as the fourth vaccine in its arsenal to fight the deadly pandemic, adding that the next in line is the Pfizer vaccine.Member of NITI Aayog,…

Immunologists have discovered a previously unknown mechanism of a type of white blood cells which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for Covid-19.The researchers,…

The Chief of Lancet Covid-19 Commission has dismissed claims by the Chinese government that he is being pushed by the US government to favour the Wuhan lab-leak theory, the media reported on Tuesday.There is "no outside interference…

Mumbai-based pharma company Cipla will add Moderna to the list of Covid-19 vaccines available in India for restricted emergency use.Sources said that the company has received permission from Drugs Controller General of India (DCGI) to…

Covid-19 vaccines are highly effective in preventing severe infections or death, but patients with multiple myeloma -- a type of blood cancer --- are immunocompromised and often on immunosuppressive therapy.The mRNA-based Pfizer and Moderna…

Taking the first dose of Pfizer Covid vaccine and then AstraZeneca for the second can provide good protection against the pandemic virus, a study has found.The Com-Cov trial, led by researchers from the University of Oxford, looked at the…

Pfizer and Moderna vaccines, the first two jabs authorised for emergency use against Covid-19 by the US Food and Drug Administration (FDA), produce immune responses that are both strong and potentially long-lasting, finds a study.While both…

Two doses of CoronaVac, a Covid-19 vaccine manufactured by Chinese firm Sinovac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a results of phase 1/2 clinical trial

Researchers at Washington University School of Medicine in St. Louis have found evidence that the immune response to Covid-19 vaccines, namely Pfizer and Moderna, is both strong and potentially long-lasting.The researchers extracted cells